Metformin reduces new-onset atrial fibrillation risk rather than atrial fibrillation burden in type 2 diabetes patients: A case-control study

Metformin reduces new-onset atrial fibrillation risk rather than atrial fibrillation burden in type 2 diabetes patients: A case-control study

Background: The effects of metformin on atrial fibrillation (AF) in type 2 diabetes patients remain unclear. We aimed to explore the effects of metformin on AF, including new-onset AF and AF burden, in type 2 diabetes patients with pacemakers. Methods and results: This retrospective study included a...

Full description

Bibliographic Details
Main Authors: Chongxia Zhong, Jian Bai, Xinhong Qu, Yihai Liu, Zhu Li, Han Hao, Shiyang Qiao, Zhe Zhang, Xiaoying Xu, Jiayi Si, Wei Xu, Biao Xu, Lina Kang
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Heliyon
Subjects:
Diabetes mellitus
Metformin
New-onset atrial fibrillation
Atrial fibrillation burden
Pacemaker
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024070233

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024070233

Similar Items